PHARMAKON

Medizin

Ribaxamase – vom Resistenz-mechanismus zum Therapeutikum
pp. 92-93(2)

Virologie

Silvestrol: Ein pflanzlicher Naturstoff mit antiviraler Wirkung
pp. 93-93(1)

Cannabis in medicine – a review of history
pp. 95-102(8)
Author: Fankhauser, Manfred

Cannabis sativa and hundreds of cultivars: is there a "best" drug?
pp. 104-108(5)
Author: Novak, Johannes

Cannabis and cannabinoids – a pharmacological update
pp. 109-117(9)
Author: Hinz, Burkhard

Cannabidiol: From the plant to the drug compound
pp. 118-122(5)
Author: Gütlein, Jörg-Peter

Cannabidiol: the rising star among the cannabinoids?
pp. 123-128(6)
Authors: Häußermann, Klaus; Wagner, Ute

The DAC monograph ,,cannabis flowers"
pp. 130-136(7)
Author: Hörnig, Michael

Clinical use of cannabinoids
pp. 137-141(5)
Authors: Likar, Rudolf; Köstenberger, Markus; Neuwersch, Stefan

Biotechnological synthesis of tetrahydrocannabinolic acid
pp. 142-147(6)
Authors: Stehle, Felix; Degenhardt, Friederike; Zirpel, Bastian; Kayser, Oliver

Cannabis for medical use – the regulatory framework in Germany
pp. 148-151(4)
Authors: Knöss, Werner; Reh, Klaus; Norwig, Jochen; Cremer-Schaeffer, Peter

Structure and function of the cannabinoid receptor CB₁
pp. 152-156(5)
Authors: Schierle, Simone; Merk, Daniel

Fragebogen
pp. 158-159(2)